Vivek Ramaswamy, Director at Roivant Sciences Ltd. (ROIV), sold 4,000,000 shares at $7.95 ($31.8M) on 2023-02-22, disclosed to the SEC on 2023-02-22.
Open-market sale of $31.8M ROIV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ROIV | SELL | 2025-09-05 | $30.0M | — | Filing → |
| ROIV | SELL | 2025-06-23 | $26.2M | — | Filing → |
| ROIV | SELL | 2025-06-06 | $14.7M | — | Filing → |